Brief: Sensei Biotherapeutics Reports Qtrly Net Loss Per Share Of $0.32

Faeth Therapeutics

09/11/2021 13:57

Nov 9 (Reuters) - Sensei Biotherapeutics Inc  SNSE.O :
    * SENSEI BIOTHERAPEUTICS REPORTS THIRD QUARTER 2021 RESULTS
AND
RECENT BUSINESS HIGHLIGHTS
    * SENSEI BIOTHERAPEUTICS INC - EXPECTS CURRENT CASH BALANCE
TO
FUND OPERATIONS AT LEAST INTO FIRST HALF OF 2024
    * SENSEI BIOTHERAPEUTICS INC - QTRLY NET LOSS PER SHARE
$0.32
    * SENSEI BIOTHERAPEUTICS INC - CASH, CASH EQUIVALENTS AND
MARKETABLE SECURITIES WERE $156.7 MILLION AS OF SEPTEMBER 30,
2021

Source text for Eikon:  ID:nGNX6Lf9GL 
Further company coverage:  SNSE.O 

 ((Reuters.Briefs@thomsonreuters.com;))